Pediatric blood & cancer · 2026
The MedSupport Multilevel Intervention to Enhance Support for Pediatric Medication Adherence: Development and Feasibility Testing.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bouchard Elizabeth G, Patel Hital, Vincent Paula C, Kahn Justine, Bona Kira, Tran Thai Hoa, Rodriguez Elisa M, Attwood Kristopher, Kelly Kara M
Аннотация
INTRODUCTION: We developed MedSupport, a multilevel medication adherence intervention designed to address root barriers to medication adherence. This study sought to explore the feasibility and acceptability of the MedSupport intervention strategies to support a future full-scale randomized controlled trial.
DESIGN, SETTING, PARTICIPANTS, AND MEASURES: We recruited caregivers of pediatric patients (ages 1-18) with acute lymphoblastic leukemia (ALL) receiving oral home-based chemotherapy at Roswell Park during April and May 2023. Multidisciplinary healthcare providers who were on the care teams of enrolled patients were invited to participate. Feasibility and acceptability among caregivers and healthcare providers were assessed using standardized self-report measures and objective measures of intervention fidelity.
RESULTS: We implemented a pilot study of the MedSupport intervention at Roswell Park, and successfully implemented all study procedures. Feasibility was demonstrated through: (i) Demand: When approached for participation, 100% of eligible caregivers (N = 6) and healthcare providers (N = 8) agreed to participate. (ii) Practicality: 100% of families completed the barriers screening questionnaire on the first prompt. All families endorsed adherence barriers (range: 3-14). (iii) Acceptability: Caregivers rated the intervention as acceptable, appropriate, and feasible (mean: 4.71-5.0). Healthcare providers rated the intervention as acceptable, appropriate, and feasible (mean: 4.41-4.47). Objective data on intervention fidelity were feasible to capture and demonstrated both caregiver and healthcare provider engagement with the intervention.
CONCLUSIONS AND RELEVANCE: MedSupport is an innovative, low-cost, and scalable intervention that warrants additional examination to understand efficacy in enhancing home-based medication adherence in pediatric ALL.
DESIGN, SETTING, PARTICIPANTS, AND MEASURES: We recruited caregivers of pediatric patients (ages 1-18) with acute lymphoblastic leukemia (ALL) receiving oral home-based chemotherapy at Roswell Park during April and May 2023. Multidisciplinary healthcare providers who were on the care teams of enrolled patients were invited to participate. Feasibility and acceptability among caregivers and healthcare providers were assessed using standardized self-report measures and objective measures of intervention fidelity.
RESULTS: We implemented a pilot study of the MedSupport intervention at Roswell Park, and successfully implemented all study procedures. Feasibility was demonstrated through: (i) Demand: When approached for participation, 100% of eligible caregivers (N = 6) and healthcare providers (N = 8) agreed to participate. (ii) Practicality: 100% of families completed the barriers screening questionnaire on the first prompt. All families endorsed adherence barriers (range: 3-14). (iii) Acceptability: Caregivers rated the intervention as acceptable, appropriate, and feasible (mean: 4.71-5.0). Healthcare providers rated the intervention as acceptable, appropriate, and feasible (mean: 4.41-4.47). Objective data on intervention fidelity were feasible to capture and demonstrated both caregiver and healthcare provider engagement with the intervention.
CONCLUSIONS AND RELEVANCE: MedSupport is an innovative, low-cost, and scalable intervention that warrants additional examination to understand efficacy in enhancing home-based medication adherence in pediatric ALL.